Characterization of changes in the intestinal microbiome following combination therapy with zinc preparation and conventional treatment for children with rotavirus enteritis.
flora changes
inflammatory factors
intestinal microbiome
rotavirus enteritis
zinc preparation
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
01
2023
accepted:
06
09
2023
medline:
23
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
Rotavirus (RV) is one of the most common pathogens causing diarrhea in infants and young children worldwide. Routinely, antiviral therapy, intestinal mucosa protection, and fluid supplementation are used in clinic, however this is not efficacious in some severe cases. Zinc supplementation has previously been shown to improve resolution of symptoms from infectious diarrhea. In this study differences in response rate, duration of hyperthermia, vomiting, and diarrhea, and the persistence time of cough and lung rales in groups were compared. 16SrDNA gene sequencing technology was used to analyze and compare changes in the intestinal microflora of children with RV enteritis who received the conventional treatment with or without the zinc preparation. In addition, the correlations between the differential bacterial species and the related inflammatory factors were determined. Conventional therapy combined with the zinc preparation significantly shortened the duration of hyperthermia, vomiting, and diarrhea compared with the conventional treatment alone. In addition, the time to symptom relief showed that the absorption time of cough and lung rales was significantly shorter in the combination treatment group than that in the conventional treatment group in the children with pneumonia. Further, compared with the conventional treatment, the combined treatment significantly increased the diversity and abundances of florae as compared with the conventional treatment. This combination therapy containing zinc preparation markedly increased the abundances of Faecalibacterium, Bacteroidales, Ruminoccoccoccus, and Lachnospiraceae at the genus level. The LEfSe analysis suggested that Compared with the conventional therapy alone, the combined therapy with the zinc preparation significantly improves symptoms caused by RV. The combination therapy containing the zinc preparation significantly increases the diversity and abundances of some beneficial groups of bacteria. Further, The presence of these groups was further negatively correlated with relevant inflammatory factors. More importantly, this combination therapy containing the zinc preparation provides a reference for the clinical management of children with RV enteritis.
Sections du résumé
Background
Rotavirus (RV) is one of the most common pathogens causing diarrhea in infants and young children worldwide. Routinely, antiviral therapy, intestinal mucosa protection, and fluid supplementation are used in clinic, however this is not efficacious in some severe cases. Zinc supplementation has previously been shown to improve resolution of symptoms from infectious diarrhea.
Methods
In this study differences in response rate, duration of hyperthermia, vomiting, and diarrhea, and the persistence time of cough and lung rales in groups were compared. 16SrDNA gene sequencing technology was used to analyze and compare changes in the intestinal microflora of children with RV enteritis who received the conventional treatment with or without the zinc preparation. In addition, the correlations between the differential bacterial species and the related inflammatory factors were determined.
Results
Conventional therapy combined with the zinc preparation significantly shortened the duration of hyperthermia, vomiting, and diarrhea compared with the conventional treatment alone. In addition, the time to symptom relief showed that the absorption time of cough and lung rales was significantly shorter in the combination treatment group than that in the conventional treatment group in the children with pneumonia. Further, compared with the conventional treatment, the combined treatment significantly increased the diversity and abundances of florae as compared with the conventional treatment. This combination therapy containing zinc preparation markedly increased the abundances of Faecalibacterium, Bacteroidales, Ruminoccoccoccus, and Lachnospiraceae at the genus level. The LEfSe analysis suggested that
Conclusion
Compared with the conventional therapy alone, the combined therapy with the zinc preparation significantly improves symptoms caused by RV. The combination therapy containing the zinc preparation significantly increases the diversity and abundances of some beneficial groups of bacteria. Further, The presence of these groups was further negatively correlated with relevant inflammatory factors. More importantly, this combination therapy containing the zinc preparation provides a reference for the clinical management of children with RV enteritis.
Identifiants
pubmed: 37842003
doi: 10.3389/fcimb.2023.1153701
pmc: PMC10570505
doi:
Substances chimiques
Zinc
J41CSQ7QDS
Banques de données
figshare
['10.6084/m9.figshare.24147222']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1153701Informations de copyright
Copyright © 2023 Xu, Zhang, Huo, Tao, Jin, Zhang, Wang, Zhu, Li, Yao and Ge.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Gastroenterology. 2013 Aug;145(2):396-406.e1-10
pubmed: 23665276
J Appl Microbiol. 2003;95(1):44-53
pubmed: 12807453
Int J Cardiol. 2014 Nov 15;177(1):144-5
pubmed: 25499362
Am J Transl Res. 2022 Feb 15;14(2):1043-1050
pubmed: 35273706
Microbiome. 2017 Apr 27;5(1):47
pubmed: 28449706
Front Pharmacol. 2019 May 31;10:603
pubmed: 31214032
ISME J. 2014 Aug;8(8):1609-20
pubmed: 24522264
Science. 2012 Jun 8;336(6086):1268-73
pubmed: 22674334
Front Microbiol. 2019 Apr 18;10:825
pubmed: 31057525
Front Immunol. 2019 Mar 11;10:277
pubmed: 30915065
Diabetes Care. 2021 Sep;44(9):1970-1979
pubmed: 34253560
Front Microbiol. 2017 Apr 21;8:653
pubmed: 28484432
Dig Dis Sci. 2002 Sep;47(9):2049-55
pubmed: 12353854
Vaccine. 2021 Sep 7;39(38):5391-5400
pubmed: 34393020
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Virol J. 2021 Dec 20;18(1):254
pubmed: 34930341
Front Cell Infect Microbiol. 2021 Jan 08;10:586751
pubmed: 33489932
Curr Infect Dis Rep. 2020 Jan 28;22(2):4
pubmed: 31993758
Nat Methods. 2013 Oct;10(10):996-8
pubmed: 23955772
J Glob Health. 2019 Dec;9(2):020416
pubmed: 31555441
Nutrients. 2020 Feb 15;12(2):
pubmed: 32075234
J Nutr. 2010 May;140(5):1049-56
pubmed: 20237063
Sci Rep. 2021 Sep 9;11(1):17898
pubmed: 34504116
Cureus. 2017 Dec 2;9(12):e1903
pubmed: 29410942
Front Cell Infect Microbiol. 2021 Aug 05;11:694395
pubmed: 34422680
N Engl J Med. 1973 Nov 15;289(20):1096-7
pubmed: 4742237
Sci Rep. 2017 Mar 30;7:45559
pubmed: 28358023
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Sep;18(9):826-830
pubmed: 27655538
Gut Pathog. 2015 Feb 08;7:3
pubmed: 25793014
Parasitol Res. 2012 Apr;110(4):1347-55
pubmed: 21968954
Eur J Immunol. 2005 Sep;35(9):2648-57
pubmed: 16114110